Observe real-life allocation of atypical antipsychotics in the acute inpatient management of schizophrenia - RECONNECT-S

Study identifier:NIS-NME-XXX-2011/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A non- interventional study to observe real life usage of atypical antipsychotics in the acute inpatient management of schizophrenia.

Medical condition

schizophrenia

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

1050

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Apr 2012
Estimated Primary Completion Date: 01 Dec 2012
Estimated Study Completion Date: 01 Dec 2012

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Dec 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria